Filing Details

Accession Number:
0000886163-22-000062
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-13 19:05:42
Reporting Period:
2022-05-13
Accepted Time:
2022-05-13 19:05:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
886163 Ligand Pharmaceuticals Inc LGND Pharmaceutical Preparations (2834) 770160744
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1237556 W Matthew Foehr 5980 Horton Street, Suite 405
Emeryville CA 94608
President And Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-13 2,500 $82.76 173,354 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct